Physician

Pavan S Reddy, M.D.

According to 2025 Medicare claims, Pavan Reddy, M.D. (NPI: 1932161155) practices hematology/oncology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is CANCER CENTER OF KANSAS, P.A. (NPI: 1841251394; TIN: 481181579) and primary practice location at 67214-3728. Reddy is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), Aledade 155 National MSSP (ACO ID: A5358), and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Reddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,908 traditional Medicare patients, billed 571,786 HCPCS/CPT codes, and received $10,265,947 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 4,234 prescription claims across 669 beneficiaries totaling $5,769,090 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 227 claims. Open Payments data shows 108 records totaling $18,728. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,361,994 to $10,265,947. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,027,912 to $5,769,090. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,294 to $2,437.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,398	329,084	$5,361,994
2016	1,221	432,251	$5,876,073
2017	1,431	409,603	$6,253,752
2018	1,520	437,870	$7,909,169
2019	1,628	471,393	$8,529,159
2020	1,456	486,123	$7,903,671
2021	1,257	411,325	$7,502,632
2022	1,270	420,127	$7,921,094
2023	1,872	470,076	$9,242,222
2024	1,908	571,786	$10,265,947

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	475	4,208	$2,027,912
2016	542	5,087	$2,637,385
2017	566	4,813	$3,281,438
2018	570	4,749	$3,824,552
2019	613	5,081	$4,459,137
2020	630	4,906	$5,891,989
2021	611	4,684	$6,144,006
2022	635	4,533	$6,603,338
2023	616	4,286	$4,789,172
2024	669	4,234	$5,769,090

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	127	453	$195,918
2016	92	516	$147,445
2017	62	238	$59,759
2018	59	243	$29,841
2019	59	230	$24,421
2020	68	237	$16,331
2021	61	219	$18,677
2022	79	298	$36,117
2023	57	231	$35,397
2024	63	227	$14,987

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	870	1,834	$61
80053	Blood test, comprehensive group of blood chemicals	629	2,346	$10
36415	Insertion of needle into vein for collection of blood sample	693	2,759	$9
85027	Complete blood cell count (red cells, white blood cell, platelets), automated test	692	2,591	$6
85007	Microscopic examination for white blood cells with manual cell count	692	2,589	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	43	1,197	$973,947
Bosulif	Bosutinib	25	750	$534,764
Ninlaro	Ixazomib Citrate	40	1,122	$522,647
Verzenio	Abemaciclib	27	742	$401,694
Tagrisso	Osimertinib Mesylate	22	660	$373,112

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8030	Breast prosthesis, silicone or equal, without integral adhesive	N	12	12	$5,710
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	21	24	$3,228
J8521	Capecitabine, oral, 500 mg	N	14	67	$2,449
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	16	73	$1,280
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$955

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	108	$18,728	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pavan S. Reddy, M.D.?

Tedicare shows public-source Medicare data for Pavan S. Reddy, M.D. (NPI 1932161155), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pavan S. Reddy, M.D. have ACO affiliation data?

Pavan S. Reddy, M.D. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616), Aledade 155 National MSSP (MSSP, ACO ID A5358), and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Pavan S. Reddy, M.D.?

Pavan S. Reddy, M.D. is linked to CANCER CENTER OF KANSAS, P.A. (billing NPI 1841251394) in the available physician profile data.

Does Pavan S. Reddy, M.D. have Open Payments data?

Pavan S. Reddy, M.D. has 108 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.